The National Institutes of Health awarded Tulane School of Medicine a contract for up to $8.5 million over five years to develop a more effective and longer-lasting vaccine against pertussis, more commonly known as “whooping cough.”
Microbiologist Lisa Morici, PhD, and immunologist James McLachlan, PhD, will lead the project to use outer membrane vesicles, which are nanoparticles shed by bacteria as they grow, to stimulate a more potent immune response than current vaccines against the disease.
Worldwide, there are an estimated 24.1 million cases of pertussis and about 160,700 deaths per yea